Rare tumors
In this section we cover the diagnosis, classification and treatment of rare tumors and hematological malignancies for physicians and medical scientists interested in uncommon neoplasms.
Rare tumors include sarcomas, rare thoracic tumors (mesothelioma, thymic neoplasms), neuroendocrine tumors, digestive rare cancers, rare skin cancers and non-cutaneous melanoma, head and neck cancers, endocrine gland tumors, rare female genital cancers, central nervous system neoplasms and rare urological and male genital tumors.
Rare cancers can be defined as cancers with a prevalence of fewer than 5 cases per 100,000 people. A cancer is rare if it affects a child or teenager. Cancer only affects a very small number of in children and teenagers. This means any cancer in a child or teenage is a rare cancer.
Rare cancers pose particular challenges for researchers as fewer patients means its harder to test possible therapies and its more difficult to get tumor tissue to help researchers to study the cancer. Cancer treatment is usually planned by a multidisciplinary team who have expert knowledge of the cancer subtype.
The articles in this section cover the latest from prostate cancer from different perspectives including clinical, research and patient. Oncology Central features the latest breaking news, peer-reviewed research articles, expert opinion pieces and more. If you want access to all of this and more content, and regular updates to your emails, register with Oncology Central now.